2017 to 2022 Saw Rise in ED Orders for Buprenorphine for Opioid Use Disorder
By Lori Solomon HealthDay Reporter
THURSDAY, Feb. 27, 2025 -- Emergency clinicians in California increased prescription of buprenorphine for opioid use disorder (OUD) from 2017 to 2022, according to a study published online Feb. 19 in the Journal of the American Medical Association.
Annette M. Dekker, M.D., from the University of California, Los Angeles, and colleagues examined emergency clinician buprenorphine initiation for OUD, subsequent prescriptions, and changes over time in California in an observational retrospective study. The analysis included data from the California Controlled Substance Utilization Review and Evaluation System (2017 through 2022).
The researchers identified 345,024 patients receiving 3.8 million buprenorphine prescriptions from 21,099 clinicians in California during the study period. At the time of first buprenorphine prescription, patients' mean age was 37 years and 67 percent were male. Over time, emergency clinicians increased from 2 percent (78 clinicians) to 16 percent (1,789 clinicians) of buprenorphine prescribers. Similarly, there was an increase in the proportion of buprenorphine initiation prescriptions by emergency clinicians (0.1 percent [53 clinicians] to 5 percent [4,493 clinicians]). For patients receiving an emergency department initiation, the continuation ratio to receive a second prescription within 40 days was 2.8. Within 40 days of emergency department buprenorphine initiation, the continuation ratio for patients to start 180 days or more of continuous prescriptions was 18.3. The continuation ratio was 9.1 within one year.
"For a lot of people who use opioids, the emergency department might be the only touch point they have with the health care system, so it’s a huge window of opportunity to make a difference," Dekker said in a statement.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
Previous Estimates of Illicit Opioid Use in the United States Underreported
WEDNESDAY, May 14, 2025 -- Illicit opioid use may be higher than previously reported in the United States, according to a study published online May 9 in JAMA Health...
Rates of Fentanyl Nonfatal Overdose ED Visits Rose Through Third Quarter of 2023
WEDNESDAY, May 14, 2025 -- From 2020 to 2023, there was an increase in the rates of fentanyl-involved nonfatal overdose emergency department visits, according to research...
Nearly 19 Million Children Live Under Same Roof as Parent With Substance Use Disorder
TUESDAY, May 13, 2025 -- In 2023, nearly 19 million children in the United States were estimated to be living in a household with at least one parent or primary caregiver with a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.